Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Specific residues of PB2 and PA influenza virus polymerase subunits confer the ability for RNA polymerase II degradation and virus pathogenicity in mice.

Llompart CM, Nieto A, Rodriguez-Frandsen A.

J Virol. 2014 Mar;88(6):3455-63. doi: 10.1128/JVI.02263-13. Epub 2014 Jan 8.

2.

Deciphering the acylation pattern of Yersinia enterocolitica lipid A.

Reinés M, Llobet E, Dahlström KM, Pérez-Gutiérrez C, Llompart CM, Torrecabota N, Salminen TA, Bengoechea JA.

PLoS Pathog. 2012;8(10):e1002978. doi: 10.1371/journal.ppat.1002978. Epub 2012 Oct 25.

3.

Molecular basis of Yersinia enterocolitica temperature-dependent resistance to antimicrobial peptides.

Reinés M, Llobet E, Llompart CM, Moranta D, Pérez-Gutiérrez C, Bengoechea JA.

J Bacteriol. 2012 Jun;194(12):3173-88. doi: 10.1128/JB.00308-12. Epub 2012 Apr 13.

4.

Role of lipid A acylation in Yersinia enterocolitica virulence.

Pérez-Gutiérrez C, Llobet E, Llompart CM, Reinés M, Bengoechea JA.

Infect Immun. 2010 Jun;78(6):2768-81. doi: 10.1128/IAI.01417-09. Epub 2010 Apr 12.

5.

Expression of the Yersinia enterocolitica pYV-encoded type III secretion system is modulated by lipopolysaccharide O-antigen status.

Pérez-Gutiérrez C, Llompart CM, Skurnik M, Bengoechea JA.

Infect Immun. 2007 Mar;75(3):1512-6. Epub 2006 Dec 18.

6.

Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides.

Campos MA, Vargas MA, Regueiro V, Llompart CM, Albertí S, Bengoechea JA.

Infect Immun. 2004 Dec;72(12):7107-14.

Supplemental Content

Loading ...
Support Center